First Indigenous Tumour Antigen of India
♦ Dr. Anil Suri, who heads the Cancer Research Program at NII (National Institute of Immunology, New Delhi), discovered India’s first indigenous tumour antigen SPAG9 in 1998.
♦ The Department of Biotechnology funds the Cancer Research Program (DBT).
♦ The SPAG9 antigen has been given the trademark ASPAGNIITM.
♦ ASPAGNIITM is being used for dendritic cell (DC)-based immunotherapy for cervical cancer, ovarian cancer and breast cancer.